Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in Bilateral Nasal Polyposis and Asthma
NCT01393340Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2006
- Primary completion
- Oct 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nasal polyposis and asthma comparing Placebo with Omalizumab (2 arms). Primary endpoint: Effect of Omalizumab on nasal polyp size and evolution of nasal polyps at 20 weeks. Started Dec 2006; status: completed.
02
Drugs
omalizumab
03
Conditions
nasal polyposisasthma
Beyond the preview
Go deeper on NCT01393340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393340.